NCT05443139 is a NA clinical trial of Well-being online in Anxiety, sponsored by Universidad Internacional de Valencia.

Who is sponsoring NCT05443139?

NCT05443139 is sponsored by Universidad Internacional de Valencia.

What drugs are being tested in NCT05443139?

Interventions in NCT05443139: Well-being online.

What condition does NCT05443139 study?

NCT05443139 studies Anxiety, Depression, Wellbeing, Stress.

Is NCT05443139 still recruiting?

NCT05443139 is currently status unknown. Last updated 18 January 2023.

Last reviewed 2023-01-18 · How we verify

NCT05443139

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Online Multi-component Psychological Intervention for Depression, Anxiety and Well-being in 7 Countries

Status unknown NA Last updated 18 January 2023

What this trial tests

NA trial testing Well-being online in Anxiety in 200 participants. Status unknown.

Timeline

23 December 2022

Primary endpoint
23 December 2023

1 November 2024

Quick facts

Lead sponsor	Universidad Internacional de Valencia
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	200
Start date	23 December 2022
Primary completion	23 December 2023
Estimated completion	1 November 2024
Sites	8 locations across Netherlands, Ecuador, Peru, Mexico, Spain, Brazil

Drugs / interventions tested

Well-being online

Conditions studied

Anxiety — all drugs for Anxiety →
Depression — all drugs for Depression →
Wellbeing — all drugs for Wellbeing →
Stress — all drugs for Stress →

Sponsor

Universidad Internacional de Valencia

Who can join

18 and older, any sex, with Anxiety or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effectiveness of an online Multi-component psychological intervention, that is focused on providing self-support to the population of 5 Latin American countries and 2 European Countries. The objectives of the intervention are: 1) To reduce the symptoms of anxiety and depression in the adult population, 2) To increase the levels of subjective well-being.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Internet-based self-administered intervention to reduce anxiety and depression symptomatology and improve well-being in 7 countries: protocol of a randomized control trial.
Dominguez-Rodriguez A, Herdoiza-Arroyo PE, González-Ramírez LP, Martínez-Arriaga RJ, et al · · 2024 · cited 1× · PMID 38774723 · DOI 10.3389/fpsyg.2024.1279847

Verify or expand the search:

Other recruiting trials for Anxiety

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting

Other Universidad Internacional de Valencia trials

Trials by the same sponsor.

NCT04890665 — Online Multi-component Psychological Intervention for Healthcare Workers During COVID-19 Pandemic · NA · unknown
NCT04813224 — Intervention Through EMDR and CBT With Women Victim of Childhood Sexual Abuse. A Randomized Controlled Trial. · NA · unknown
NCT04638842 — Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19 · NA · completed
NCT04468893 — Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19 · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05443139 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Internacional de Valencia
Last refreshed: 18 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05443139.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing